Skip to main content
H.R. 4975 113th Congress House

SALTS Act

Official title: To amend the Controlled Substances Act relating to controlled substance analogues.

Introduced: June 25, 2014 See on congress.gov
Crime and Law Enforcement Drug trafficking and controlled substancesDrug, alcohol, tobacco useMarketing and advertising
This bill died when the 113th Congress ended
It never became law before the 113th Congress (2013–2014) adjourned, and bills don't carry over to the next Congress. It would have to be reintroduced. You can still save it for reference, but it won't receive updates.
 Everywhere this bill has been 3 steps
Introduced
In committee
Reported out
Passed House
Passed Senate
To President
Became law
Jul 21, 2014
Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.
Jun 25, 2014
Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Jun 25, 2014
Introduced in House
 Ask about this bill AI · grounded in the bill text

Have a question about what this bill does? Ask in plain English; the answer is drawn from the bill's actual text and official record, and it'll tell you when something isn't in the text rather than guess.

AI answers can be imperfect; always confirm against the full bill text.

 Latest action July 21, 2014

Referred to the Subcommittee on Crime, Terrorism, Homeland Security, and Investigations.

 Plain-English summary Congressional Research Service

Synthetic Abuse and Labeling of Toxic Substances Act of 2014 or the SALTS Act - Amends the Controlled Substances Act to provide that, in determining whether a controlled substance analogue was intended for human consumption, the following factors may be considered: (1) the marketing, advertising, and labeling of the substance; (2) the known efficacy or usefulness of the substance for the marketed, advertised, or labeled purpose; (3) the difference between the price at which the substance is sold and the price at which the substance it is purported to be or advertised as is normally sold; (4) the diversion of the substance from legitimate channels and the clandestine importation, manufacture, or distribution of the substance; and (5) whether the defendant knew or should have known that the substance was intended to be consumed by injection, inhalation, ingestion, or any other immediate means.

Declares that evidence that a substance was not marketed, advertised, or labeled for human consumption shall not by itself be sufficient to establish that the substance was not intended for human consumption.

 Related & companion bills 1
 Bill text 1 version

Source documents hosted by congress.gov.

 Committees of jurisdiction 3
Cite this page click to expand
APA
U.S. Congress. (2026). H.R. 4975: SALTS Act. 113th Congress. Open America. https://openamerica.io/bill/113-HR-4975/
MLA
"H.R. 4975: SALTS Act." 113th Congress, 2026, Open America, https://openamerica.io/bill/113-HR-4975/.
Bluebook (legal)
H.R. 4975, 113th Cong. (2026), https://openamerica.io/bill/113-HR-4975/.
Markdown link
[H.R. 4975: SALTS Act](https://openamerica.io/bill/113-HR-4975/)
Report a problem